What is Genomic Profiling?
Using tumor tissue from surgery or biopsy, laboratories can study the genomic characteristics of each tumor. This information is then passed to your oncologist who can make a more targeted treatment decision based on your tumor’s make up. Rather than creating a treatment plan from high level information such as the location of the tumor, treatment decisions are taken based on specific mutations expressed on the tumor.
Profiling often reveals treatment options beyond the current standard of care (because some of the drugs can be experimental). Profiling also typically adds a category of targeted drugs that is not always considered as a part of the standard of care.
Are there different types of Genomic Tests?
Yes, many companies and hospitals offer various versions of this test. Some offer panels that check for a larger number of mutations and some with smaller, more focused panels. Some study normal and cancerous tissue and focus on mutations that are exclusively cancerous. Others leverage different technology platforms to cross check and confirm their results. There are different approaches that we can help you compare when applicable.
It is also important to note that due to tumor heterogiety, results are not always accurate, and for best clinical insight it is often best to combine the results from this test with results from chemo sensitivity or drug screening.
Who is a Candidate for Genomic Profiling?
Genomic profiling is available to every patient who has any type of cancer. More specifically to patients:
- with aggressive disease or disease of unknown origin
- with advanced stage cancer or metastasis
- where the cancer has recurred
- whose cancer is not responding to traditional treatments
- with multiple treatment options
- experiencing too many side effects from my current treatment
- being told that there are no other treatment options available to me
- that have or (or think they may have) developed resistance to their current treatment
Request more information about Genomic Profiling or schedule a free consultation with one of our advisors.
A call with a patient advisor from StoreMyTumor is the quickest way to get answers to your questions. This is a free conversation, and there is no obligation to utilize StoreMyTumor.
Your tumor is preserved in multiple formats for further study, immediately or at a later time. It is ideal for every cancer patient. Learn more about Tumor Preservation.
Chemo Sensitivity Testing
Tests which chemotheraputic agents will work on the tumor from day one, and and which will not. Learn more about Chemo Sensitivity Testing.
Identifies mutations on your tumor that help your oncologist prescribe more targeted drugs based on your tumor makeup. Learn more about Genomic Profiling.
Tests chemotherapy agents and tens of additional experimental and immunotherapy drugs to find the right combination for a particular tumor. Learn more about Drug Screening.
Immunotherapy designed to treat cancers that have already developed (as opposed to preventative). It educates the immune system to attack your cancer cells. Learn more about Personalized Vaccines.
Adoptive T-Cell Therapy
Immunotherapy approach that attempts to boost the natural ability of the patient’s T-cells (killer cells) to attack and fight your cancer cells. Learn more about Adoptive T-Cell Therapy.